Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2023
Source ID
10.1016/j.phrs.2023.106692

Entities

People

  • Allen C Gao
  • Bo Chen
  • Chengfei Liu
  • Christopher Nip
  • Christopher P Evans
  • Jason E Gestwicki
  • Joy C. Yang
  • Liangren Liu
  • Oleta T. Johnson
  • Pengfei Xu
  • Qiang Wei
  • Shu Ning

Organizations

  • National Cancer Institute
  • National Institutes of Health
  • United States Department of Defense
  • University of Michigan Rogel Cancer Center